Vertex Pharmaceuticals
VRTX
#150
Rank
A$202.41 B
Marketcap
A$798.34
Share price
0.42%
Change (1 day)
19.43%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): A$6.65 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are A$12.95 Billion. In 2025 the company made an earning of A$7.17 Billion, an increase over its 2024 earnings that were of A$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$6.65 B-7.29%
2025 A$7.17 B1627.59%
2024 A$0.41 B-93.69%
2023 A$6.58 B3.19%
2022 A$6.38 B53.56%
2021 A$4.15 B-12.06%
2020 A$4.72 B118.45%
2019 A$2.16 B120.64%
2018 A$0.98 B1473.64%
2017 A$62.29 M197.6%
2016 A$20.93 M-102.97%
2015 -A$0.71 Billion-28.46%
2014 -A$0.99 Billion-51.5%
2013 -A$2.04 Billion-30584.68%
2012 A$6.66 M-95.47%
2011 A$0.14 B
2009 -A$0.89 Billion
2007 -A$0.62 Billion83.1%
2006 -A$0.34 Billion59.02%
2005 -A$0.22 Billion3.28%
2004 -A$0.21 Billion-38.16%
2003 -A$0.34 Billion
2000 -A$56.62 Million-20.38%
1999 -A$71.11 Million31.62%
1998 -A$54.03 Million91.05%
1997 -A$28.28 Million-36.24%
1996 -A$44.35 Million12.45%
1995 -A$39.44 Million27.4%
1994 -A$30.96 Million-1833.33%
1993 A$1.78 M-112.12%
1992 -A$14.74 Million175%
1991 -A$5.36 Million-12.2%
1990 -A$6.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$27.86 B 310.44%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$19.06 B 180.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-A$3.77 Billion-155.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.00 B 47.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$16.86 B 148.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-A$74.73 Million-101.10%๐Ÿ‡บ๐Ÿ‡ธ USA